Afya (NASDAQ: AFYA) has recently received a number of price target changes and ratings updates:
- 1/31/2026 – Afya was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
- 1/21/2026 – Afya had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
- 1/16/2026 – Afya was upgraded by analysts at Sanford C. Bernstein to a “market perform” rating.
- 1/16/2026 – Afya had its “neutral” rating reaffirmed by analysts at UBS Group AG. They now have a $16.00 price target on the stock, down previously from $18.00.
- 1/16/2026 – Afya was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $16.00 price target on the stock, down previously from $18.00.
- 1/10/2026 – Afya was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
- 1/9/2026 – Afya was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
- 1/8/2026 – Afya had its price target lowered by analysts at UBS Group AG from $19.00 to $18.00. They now have a “buy” rating on the stock.
- 1/7/2026 – Afya had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $22.00 price target on the stock, down previously from $24.50.
- 12/20/2025 – Afya was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Articles
- Five stocks we like better than Afya
- NEW LAW: Congress Approves Setup For Digital Dollar?
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Afya Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya Limited and related companies with MarketBeat.com's FREE daily email newsletter.
